Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Amyris Inc | AMRS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.05 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.05 - 1.32 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.05 | USD |
Amyris Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 18.47M | - | - | - | -9.55 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Amyris News
Date | Time | Source | News Article |
---|---|---|---|
4/23/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
4/08/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
4/02/2024 | 05:06 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
1/05/2024 | 15:22 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
1/04/2024 | 15:35 | Edgar (US Regulatory) | Form 8-K - Current report |
12/29/2023 | 15:09 | Edgar (US Regulatory) | Form 8-K - Current report |
12/27/2023 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
8/17/2023 | 18:35 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
8/15/2023 | 15:39 | Edgar (US Regulatory) | Form 8-K - Current report |
8/14/2023 | 06:15 | IH Market News | Monday’s Wall Street Highlights: US Steel, Tesla, Nikola,.. |
8/11/2023 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
8/10/2023 | 07:54 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMRS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.77 | 1.32 | 0.05 | 0.285157 | 19,845,703 | -0.72 | -93.51% |
3 Years | 15.20 | 17.42 | 0.05 | 3.20 | 7,368,680 | -15.15 | -99.67% |
5 Years | 4.88 | 23.42 | 0.05 | 4.11 | 5,099,733 | -4.83 | -98.98% |
Amyris Description
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services. |